HoneycombWe believe our investment opportunities are priced competitively and have a purpose built strong alignment of interests between all parties. Having been involved in the product origination, design and due diligence, we are proud to have put the ‘Kin’ name to them.





Our focus is providing financial intermediaries with investment opportunities that convey tax significant advantages for their clients. At Kin Capital we believe suitably qualified professionals such as IFAs, wealth managers, tax and other advisors can add considerable value when making decisions about tax, financial planning  and investments. Human psychology is such that even the most experienced investors can benefit from a professional dispassionate view. We accept however that not everyone shares our belief. Please note, in order to give you access to further information on certain products, we may require you to confirm whether you meet the FCA’s definitions of a High Net Worth Investor, Sophisticated Investor or Restricted Investor.



What the Patient Capital Review means for the tax efficient industry

The Patient Capital Review is two months late and as a result, warns Tom Hopkins, there is a danger some decisions could be rushed through in time for the Autumn Statement and based on out-of-date statistics Read more...

Kin Capital Announces New Hires and Services

On the back of strong market growth and demand for its services Kin Capital has expanded the team and new services to those working in the tax efficient market. Read more...

Pembroke VCT – Dividend Declaration

Pembroke Venture Capital Trust (VCT) continues to deliver for investors with proposed final dividend Read more...

See all news >